Effect of Zoledronic Acid on Bone Mineral Density in Men with Prostate Cancer Receiving Gonadotropin-Releasing Hormone Analog

<table class="table-group" width="800px"><tr class="fig-image" id="a"><td><img alt="176164.fig.002a" src="https://static.hindawi.com/articles/pc/volume-2011/176164/figures/176164.fig.002a.jpg"/></td></tr><tr class="fig-caption"><td align="center"><table><tr><td><b>(a) </b>Serum creatinine</td></tr></table></td></tr><tr class="fig-image" id="b"><td><img alt="176164.fig.002b" src="https://static.hindawi.com/articles/pc/volume-2011/176164/figures/176164.fig.002b.jpg"/></td></tr><tr class="fig-caption"><td align="center"><table><tr><td><b>(b) </b>Serum calcium</td></tr></table></td></tr><tr class="fig-image" id="c"><td><img alt="176164.fig.002c" src="https://static.hindawi.com/articles/pc/volume-2011/176164/figures/176164.fig.002c.jpg"/></td></tr><tr class="fig-caption"><td align="center"><table><tr><td><b>(c) </b>Urine NTX</td></tr></table></td></tr><tr class="fig-image" id="d"><td><img alt="176164.fig.002d" src="https://static.hindawi.com/articles/pc/volume-2011/176164/figures/176164.fig.002d.jpg"/></td></tr><tr class="fig-caption"><td align="center"><table><tr><td><b>(d) </b>Serum osteocalcin</td></tr></table></td></tr><tr class="fig-image" id="e"><td><img alt="176164.fig.002e" src="https://static.hindawi.com/articles/pc/volume-2011/176164/figures/176164.fig.002e.jpg"/></td></tr><tr class="fig-caption"><td align="center"><table><tr><td><b>(e) </b>Serum BSAP</td></tr></table></td></tr></table>

<table>Comparison of biomarker levels between that two groups at each time point.</table>

Prostate Cancer

fig2

Figure 2

Figure 2: Effect of Zoledronic Acid on Bone Mineral Density in Men with Prostate Cancer Receiving Gonadotropin-Releasing Hormone Analog 